TRAF3 regulates STAT6 activation and T-helper cell differentiation by modulating the phosphatase PTP1B
The adaptor protein tumor necrosis factor receptor-associated factor 3 (TRAF3) is a multifaceted regulator of lymphocyte biology that plays key roles in modulation of the molecular signals required for T-cell activation and function. TRAF3 regulates signals mediated by the T-cell receptor (TCR), costimulatory molecules, and cytokine receptors, which each drive activation of the serine/threonine kinase Akt. The impact of TRAF3 upon TCR-CD28-mediated activation of Akt, and thus on the diverse cellular processes regulated by Akt, including CD4 T-cell fate decisions, remains poorly understood. We show here that TRAF3 deficiency led to impaired Akt activation and thus to impaired in vitro skewing of CD4 T cells into the T<sub>H</sub>1 and T<sub>H</sub>2 fates. We investigated the role of TRAF3 in regulation of signaling pathways that drive T<sub>H</sub>1 and T<sub>H</sub>2 differentiation and found that TRAF3 enhanced activation of signal transducer and activator of transcription 6 (STAT6), thus promoting skewing toward the T<sub>H</sub>2 fate. TRAF3 promoted STAT6 activation by regulating recruitment of the inhibitory molecule protein tyrosine phosphatase 1B to the IL-4R signaling complex, in a manner that required integration of TCR-CD28- and IL-4R-mediated signals. This work reveals a new mechanism for TRAF3-mediated regulation of STAT6 activation in CD4 T cells and adds to our understanding of the diverse roles played by TRAF3 as an important regulator of T-cell biology.
Authors
- Tina Arkee (ORCID: https://orcid.org/0000-0003-4983-8958)
- Emma E. Hornick (ORCID: https://orcid.org/0000-0002-1355-0576)
- Gail A. Bishop (ORCID: https://orcid.org/0000-0002-1291-5078)
Institutions
- University of Iowa (US)
Publication Details
- Journal
- Journal of Biological Chemistry
- Published
- 2024-09-03
- DOI
- https://doi.org/10.1016/j.jbc.2024.107737
- Citations
- 4
- Primary Topic
- NF-κB Signaling Pathways
- Type
- article
- Field-Weighted Citation Impact
- 1.14
Funders
- U.S. Department of Veterans Affairs
- Office of Research and Development
- Health Services Research and Development
- University of Iowa
- National Institutes of Health
- Holden Comprehensive Cancer Center, University of Iowa
- Roy J. and Lucille A. Carver College of Medicine, University of Iowa
- National Cancer Institute